Coluracetam lunarizine dihydrochloride AT-56 is an orally active

AT-56 is an orally active and selective inhibitor of lipocalin-type prostaglandin (PG) D synthase (L-PGDS) with Ki of 75 μM and IC50 of 95 μM

19(1):291-300

A Chemoproteomic Approach to Query the Degradable Kinome Using a Multi-kinase Degrader

Like other quinolones and fluoroquinolones the compound eradicates bacteria by interfering with DNA replication (bacterial DNA replication

Coluracetam lunarizine dihydrochloride AT-56 is an orally activeColuracetam, also known as BCI 540; MKC 231, is a AMPA receptor agonist potentially for the treatment of major depression and anxiety. MKC 231 antagonizes phencyclidine induced behavioral deficits and reduction in septal cholinergic neurons in rats. MKC 231 ameliorates working memory deficits and decreased hippocampal acetylcholine induced by ethylcholine aziridinium ion in mice. Product information CAS Number: 135463 81 9 Molecular Weight: 341. 40